RCM
RENE

Radcliffe Capital Management’s Cartesian Growth Corp II RENE Stock Holding History

Radcliffe Capital Management’s Portfolio RENE Stock Details RENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-573,689
Closed -$6.37M – 47
2024
Q1 		$6.37M Sell
573,689
-73,867
-11% -$816K 1.21% 18
2023
Q4 		$7.09M Buy
647,556
+69,476
+12% +$756K 0.95% 24
2023
Q3 		$6.26M Sell
578,080
-49,670
-8% -$533K 0.78% 34
2023
Q2 		$6.7M Sell
627,750
-10,752
-2% -$114K 0.57% 40
2023
Q1 		$6.7M Buy
638,502
+182,090
+40% +$1.89M 0.42% 64
2022
Q4 		$4.68M Buy
456,412
+156,412
+52% +$1.59M 0.15% 212
2022
Q3 		$3.02M Buy
+300,000
New +$3.01M 0.07% 458

Other funds holding RENE

FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.46% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

Radcliffe Capital Management's RENE Position: Q2 2024 in Review

Radcliffe Capital Management sold out of Cartesian Growth Corp II (RENE) in Q2 2024, closing a stake of 573,689 shares — an estimated $6.37M sold.

Radcliffe Capital Management first reported a position in RENE in Q3 2022 and held it in 7 quarters. The position peaked at $7.09M in Q4 2023. 34 funds tracked by Wall St. Rank hold RENE as of Q2 2024.

  • Radcliffe Capital Management reported no remaining Cartesian Growth Corp II position as of Q2 2024 after selling out during the quarter.
  • Radcliffe Capital Management sold 573,689 Cartesian Growth Corp II shares in Q2 2024, an estimated $6.37M.
  • Radcliffe Capital Management first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 7 quarters.
  • Radcliffe Capital Management's Cartesian Growth Corp II position peaked at $7.09M in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2024.

Based on Radcliffe Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.